Acupuncture For CTS
Acupuncture For CTS
Acupuncture For CTS
used for the treatment of painful disorders. However, at (Daling), PC-6 (Neiguan)] on the affected side in their 8
present, there is no conclusive evidence of the efficacy of sessions without modification for the specific symptoms of
acupuncture in treatment of CTS.6,8 In an attempt to the patients. We placed patients in the supine position to
investigate whether acupuncture is as effective and safe as make them more comfortable. Sterile disposable steel
steroid in the treatment of mild-to-moderate CTS, we needles (gauge and size: 0.25 40 mm) were used without
conducted a prospective, randomized clinical study under electrical stimulation or moxibustion. At each point, the
conditions similar to routine care. skin was wiped with alcohol and needles were inserted
perpendicularly at PC-6 to a depth of 1.0 to 1.5 inch and at
PC-7 they were inserted from 0.5 to 1.0 inch according to
PATIENTS AND METHODS the thickness of the patient’s wrist. The needles were
The study protocol was approved by the institutional manipulated by twirling with lifting-thrusting methods to
review board of our hospital. produce a characteristic sensation known as De Qi (an
awareness of numbness, soreness, swelling, heaviness, or
Patients radiating feeling from the point of needling deemed to
The patients, aged from 18 to 85, enrolled in this study indicate proper needle position and effective needling) and
had clinical symptoms and signs of CTS. CTS was were then left in place for 30 minutes. For patients with
diagnosed clinically based on the presence of at least one bilateral CTS, both wrists were needled and data were
of the following primary symptoms: (1) numbness, tingling reported separately.
pain, or paresthesia in the median nerve distribution; (2) However, we included only the more-affected hand
precipitation of these symptoms by repetitive hand activ- with a higher GSS in each individual for data analysis. As
ities, which could be relieved by resting, rubbing, and only 1 hand with a higher GSS score from each individual
shaking the hand; and (3) nocturnal awakening by such was used for analysis, the number of participants was equal
sensory symptoms. The diagnosis was often supported by a to the number of affected arms enrolled in the analysis set.
positive Tinel sign. All patients with clinically diagnosed All treatments were performed at the same facility by 1
CTS demonstrated median neuropathy at the wrist, acupuncturist. Additionally, the acupuncturist was asked to
confirmed by the presence of 1 or more of the following have the least possible communication with patients to
standard electrophysiologic criteria: (1) prolonged distal minimize bias. Complete details of the intervention are
motor latency (DML) to the abductor pollicis brevis (APB) presented in Table 1 in conformance to the standards for
(abnormal Z4.7 ms, stimulation over the wrist, 8 cm reporting interventions in controlled trial of acupuncture.13
proximal to the active electrode); (2) prolonged antidromic
distal sensory latency (DSL) to the second digit (abnormal Measures
Z3.1 ms; stimulation over the wrist, 14 cm proximal to the
active electrode); and (3) prolonged antidromic wrist-palm Electrophysiologic Assessment
sensory nerve conduction velocity (W-P SNCV) at a The median and ulnar nerves were studied with no
distance of 8 cm (W-P SNCV, abnormal <45 m/s).9–12 If abnormality in the ulnar nerves. Motor and sensory NCS
the patients fulfilled the criteria and gave written informed were performed using standard techniques of supramaximal
consent before randomization, they were enrolled in the percutaneous stimulation and surface electrode recording.
study. Possible side effects were fully explained. At their DML and DSL, motor nerve conduction velocity, com-
first visit, we assessed their medical and neurologic history, pound muscle action potential (CMAP), sensory nerve
gave them detailed physical and neurologic examinations, action potential (SNAP) amplitudes, and W-P SNCV were
biochemical and endocrine screenings (ie, fasting blood measured using the methods described by Delisa et al.9 The
sugar, thyroid stimulating hormone, free T4), NCS and
needle electromyography. Before treatment, the patients
were followed-up for 1 month. If improvement occurred
during observational periods, patients were excluded from TABLE 1. Standards for Reporting Interventions in Controlled
this study. After enrollment, the patients were randomized Trials of Acupuncture (STRICTA)
into 2 treatment arms: (1) a group receiving 2 weeks of Acupuncture A fixed and classic acupuncture points
20 mg prednisolone daily followed by 10 mg daily for rationale (PC-7 (Daling), PC-6 (Neiguan) in their
another 2 weeks; and (2) a group receiving acupuncture in 8 8 sessions
sessions over 4 weeks. The randomization was carried out Unilateral or bilateral points
according to computer-generated randomly allocated treat- Needling details
Depth of insertion: standard to each point
ment codes and data were kept by a person not involved in
according to classic acupuncture point
the care or evaluation of the patients or in the data analysis. Responses elicited: de qi sensation
All patients received complete global symptom score (GSS) Manual: twirling with lifting-thrusting
measurements at baseline, 2, and 4 weeks and NCS at method stimulation
baseline and 4 weeks later performed by the same blinded Needles retained for 30 min
evaluator throughout the entire study period. All patients Needle type: C&G, gauge and size:
were scheduled so as to avoid any overlap during which 0.25 40 mm
they could share clinical information and experiences with Treatment regimen Twice per week for 4 wk
each other. Cointervention None: no herbs, moxibustion, cupping,
rehabilitation advice regarding dietary
Acupuncture Treatment or lifestyle modifications
Practitioner License-certificated
Acupuncture consisted of 8 sessions of 30-minute background
duration, administrated over 4 weeks (2 sessions/wk). Each Control intervention Nil
patient had fixed and classic acupuncture points [PC-7
electromyographic recording (Viking IV; Nicolet WI, improvement, we repeated NCS at the end of the
Madison, WI) of motor conduction studies were made assessment for those patients who completed the study.
with the filter band pass at 2 to 10 Hz, a sweep speed of But for the patients lost to follow-up and those who
2 ms/cm, and the amplifier gain adjusted for full reviewing received surgery, we decided not to repeat the NCS.
of the CMAP. For measurement of SNAP, the instrument Additional treatments (such as splinting and local injec-
settings were: filters, 20 Hz to 10 kHz; sweep, 2 ms/cm; gain, tions) or alterations in daily activities were not permitted
10 to 20 mV/cm. during the study.
Patients were excluded if any of the following were
present: (1) symptoms occurring less than 3 months before Safety Assessments
the study or symptoms improving during the 1-month Patients reported all serious adverse events with side
initial observation period (to exclude patients who might effects of both oral steroids treatment at weeks 2 and 4 and
have spontaneous resolution of symptoms); (2) severe CTS acupuncture treatment in each session. We recorded
that had progressed to visible muscle atrophy; (3) in our adverse side effects such as nausea, epigastric pain, tarry
study, mild CTS referred to patients with decreased stools, leg edema, cushingoid appearance, blood pressure,
conduction velocity over the palm-wrist segment and blood sugar along with ecchymosis, local paresthesia, or
delayed DSL, with normal median SNAP amplitude and bleeding to treat analysis for all enrolled patients.
CMAP amplitude of the APB. Moderate CTS referred to
patients with abnormally delayed DML and DSL with
either decreased median SNAP amplitude or decreased Statistical Analysis
CMAP amplitude of the APB muscle. Thus, CTS patients A last-observation-carried-forward approach was used
with the presence of either fibrillation potentials or to input missing data with the intent-to-treat analysis
reinnervation on needle EMG in the APB were excluded principle. Independent 2-sample t test was performed to
(to ensure the inclusion of only mildly or moderately compare the efficacy of the objective changes in nerve
affected individuals); (4) clinical or electrophysiologic conduction and subjective symptoms assessment between
evidence of accompanying conditions that could mimic the 2 groups for the baseline, 2-week and 4-week evalua-
CTS or interfere with its evaluation, such as cervical tions. Repeated measures analysis of variance with Bon-
radiculopathy, proximal median neuropathy, or significant ferroni adjustment for multiple testing was used to compare
polyneuropathy; (5) evidence of obvious underlying causes the changes in subjective symptoms assessment between
of CTS such as diabetes mellitus, rheumatoid arthritis, week 2 or 4 data and baseline data within each treatment
hypothyroidism (acromegaly), pregnancy, alcohol abuse or group. Paired t test was performed for objective changes in
drug usage (steroids or drugs acting through the central nerve conduction between week 4 data and baseline data
nervous system), use of vibrating machinery, and suspected within each treatment group. For 5 main symptoms score
malignancy or inflammation or autoimmune disease were of GSS and 6 measures of NCS, Bonferroni adjustment was
documented as underlying causes for CTS; (6) recent peptic made to control for type I error. All hypothesis testing were
ulcer or history of steroid intolerance; (7) prior unpleasant 2-tailed and level of significance was set at 0.05. All
experience with acupuncture or a bleeding diathesis; or (8) statistical analyses were performed using SPSS Version 15.0
cognitive impairment interfering with the patient’s ability to for Windows (SPSS Inc, Chicago, IL).
follow instructions and describe symptoms.
RESULTS
Clinical Assessments Enrollment of Patients and Baseline
Clinical assessments included the symptomatic ques- Characteristics
tionnaire modified from that used by Herskovitz et al14 and A total of 77 patients who fulfilled the inclusion and
by us in our previous study.10,11 We rated symptoms from 0 exclusion criteria agreed to participate in our study and
(no symptoms) to 10 (very severe symptoms) in each of 3 were randomly allocated to either the steroid or acupunc-
categories: pain, numbness, and paresthesia. Nocturnal ture treatment group. The baseline characteristics of the 2
awakening was scored by times awakened in 1 week: never, groups were similar in the intention-to-treat population
0; once or twice, 2; 3 or 4 times, 4; 5 to 7 times, 6; 8 to 10 (Table 2). Of the 77 patients, 3 patients in the acupuncture
times, 8; more than 10 times, 10. Weakness was scored group dropped out due to inability to take time off work,
according to the severity of the weakness: none, 0; mild, 2; and 4 patients in the steroid group did not finish the study
moderate, 3; severe, 4; very severe, 5; and assessed for due to intolerance of side effects of epigastric pain with
clumsiness by difficulty in manipulating small objects: none, nausea. No patients received surgery before the end of the
0; mild, 2; moderate, 3; severe, 4; very severe, 5. The total of
the scores of the 5 main symptoms was the GSS. Each
patient was directly questioned, and each score was based
on the patient’s subjective answers. Therefore, the maxi- TABLE 2. Summary of Baseline Characteristics of Study Patients
mum score was 50 (most severe symptoms) and the Acupuncture Group Steroid Group
minimum score was 0 (absence of symptoms). Furthermore, Number of patients 38 39
to ensure consistency, the evaluating physician was the Age (y) 49.3 (8.9) 49.9 (10.3)
same person on each occasion for each patient. Follow-up Sex (female/male) 38/6 39/8
assessments identical to the baseline procedure were Duration (mo) 7.6 (3.8) 7.7 (3.2)
performed at 2 and 4 weeks later. Baseline GSS 16.0 (8.7) 14.3 (7.5)
At the end of the study, neurologic examinations were
Values are number or mean (standard deviation, SD).
repeated, along with the same biochemical and endocrine GSS indicates global symptom score.
examinations as at baseline. To obtain objective evidence of
Excluded because
patients were not
interested or difficult
to find time to Total number of patients
cooperate N=13 randomized N=77
study. The dropout rate was low for both the steroid and significant difference between the 2 groups before treat-
acupuncture groups. We substituted baseline values for the ment. At the end of the study, there was a high percentage
missing data of the 7 patients who did not complete the of improvement in both the acupuncture and steroid groups
study (thus, setting differences compared with baseline to at weeks 2 and 4 (all P<0.01 for both groups), though
zero). Figure 1 illustrates patient enrollment and random statistical significance was not achieved between the 2
allocation of patients to study groups. There was no groups (P = 0.15) (Fig. 2A). Of the 5 parameter scores
difference in age, sex, or duration of symptoms between (pain, numbness, paresthesia, weakness/clumsiness, noctur-
treatment groups. nal awakening), only 1, nocturnal awakening showed a
significant decrease between the 2 groups. Patients with
Outcome of Treatment acupuncture treatment had significantly better improve-
Table 3 shows the changes in GSS for the 77 patients ment in nocturnal awakening compared with the steroid
who were available for the efficacy analysis. There was no group at week 4 (P = 0.03) (Fig. 2B).
5 ∗∗
∗∗ DISCUSSION
∗∗ The present study is one of the most rigorous trials of
the efficacy of acupuncture treatment versus proven
0
0 1 2 3 4 5
standard drugs on CTS available. Its strength includes
interventions based on expert consensus by qualified and
Time (Weeks) experienced medical acupuncturists, assessment of the
B credibility of interventions, and outcome measurements as
recommended in guidelines for trials on CTS. The results of
Change from Baseline of Nocturnal Awakening
TABLE 4. Improvement in Electrodiagnostic Measurements in Patients With Carpal Tunnel Syndrome who had Symptom Relief
Acupuncture Group Steroid Group
Electrodiagnostic Variable, With Normal Result Baseline After Treatment Baseline After Treatment Pw
DML (ms), <4.7 5.6 (0.9) 4.0 (0.7)* 5.6 (1.3) 4.7 (1.0)* 0.012
CMAP (mv), >6.5 7.2 (2.9) 7.2 (2.7) 7.2 (2.8) 7.6 (2.8)* NS
MNCV (mv), >50 53.1 (4.5) 53.7 (3.8) 51.9 (4.1) 52.4 (3.6) NS
DSL (ms), <3.1 3.7 (1.0) 3.3 (0.7)* 3.4 (0.8) 3.0 (0.6)* NS
W-P SNCV (m/s), >45 40.0 (8.6) 43.9 (8.0)* 43.3 (9.5) 48.6 (6.2)* NS
SNAP (mv), >15 15.4 (9.0) 18.4 (9.8)* 17.4 (9.3) 20.8 (9.9)* NS
*P<0.05 compared with baseline within group by paired t test with Bonferroni adjustment.
wThe change from baseline was compared between groups with independent t test.
Values are mean (standard deviation, SD).
CMAP indicates compound muscle action potential; DML, distal motor latency; DSL, distal sensory latency; MNCV, motor nerve conduction velocity;
NS, non-significant; SNAP, sensory nerve action potential; W-P SNCV, wrist-palm sensory nerve conduction velocity.
swelling because of their anti-inflammatory action. It is thus Furthermore, if both treatments are possibly effective, it is
reasonable to use oral steroids in the treatment of CTS and easy to explain and encourage patients to be recruited in
a short-term course of low-dose steroids can be of great current study. Recently, a Japanese study found that most
benefit in the treatment of mild-to-moderate people in Asian countries have knowledge about acupunc-
CTS.10,12,13,23,24 A recent study suggests that acupuncture ture and have received acupuncture treatment, and 60% of
may possess anti-inflammatory action via release of the patients could distinguish between sham and genuine
neuropeptides from nerve endings.25 There is also evidence needling.30 Our patients were also able to make this
that acupuncture processing in the brains of CTS patients distinction, so we did not choose sham acupuncture in
differs from that of healthy controls.26 It would be of great our study. Steroid treatment is one of the most common
interest to know what roles the peripheral and the central used drugs in clinical practice for treatment of mild-to-
mechanisms play in CTS patients after acupuncture moderate CTS. But in our society, most people are
treatment, although it is beyond the scope of this article. reluctant to take it. So, we set out to answer the clinically
In traditional Chinese medical literature, the acupuncture relevant question, ‘‘does acupuncture improve outcomes
point Neiguan has been shown to relieve insomnia.27 This among patients with mild-to-moderate CTS comparable to
may explain why patients who received acupuncture steroid treatment?’’ This is substantially different from the
treatment had significantly better improvement in noctur- question, ‘‘does acupuncture improve outcomes compar-
nal awakening compared with the steroid group at week 4. able to a sham procedure that appears to be similar to, but
The investigators are aware of and capable of using isn’t really, acupuncture?’’ Therefore, an active instead of
sham acupuncture28,29; however, the reason for our placebo control was used in this study, and the steroid
preference for an active drug rather than placebo was less treatment for CTS was chosen as a comparison.
ethical problem to adopt an active treatment arm for The natural history in CTS patients was not well
patients who looked for a treatment for their discomforts. characterized until a recent study by Padua et al.31 In their
study of 441 hands afflicted with idiopathic CTS, they
found that 21% of hands improved over 10 to 15 months of
1 follow-up without active intervention. Thus any therapeutic
Change from Baseline of motor distal latency
1. Is acupuncture therapy effective for long-term symptom tional conduction techniques in electro diagnosis of carpal
relief of CTS? tunnel syndrome. Clin Neurophysiol. 2006;117:984–991.
2. Do symptoms recur once acupuncture is discontinued, 13. MacPherson H, White A, Cummings M, et al. Standards for
and is further acupuncture therapy effective in patients reporting interventions in controlled trials of acupuncture: the
STRICTA recommendations. J Altern Complement Med. 2002;
experiencing a recurrence? 8:85–89.
3. What is the mechanism of acupuncture on CTS? 14. Herskovitz S, Berger AR, Lipton RB. Low-dose, short-term
To answer these questions, we are currently conduct- oral prednisone in the treatment of carpal tunnel syndrome.
ing other studies. Future studies may also consider Neurology. 1995;45:1923–1925.
additional assessments using validated commonly used 15. White A, Hayhoe S, Hart A, et al. Survey of adverse events
disability scales such as the SF-36, Disability of Arm, following acupuncture (SAFA): a prospective study of 32,000
Shoulder and Hand questionnaire to make comparison of consultations. Acupunct Med. 2001;19:84–92.
the data to other published literature more relevant. 16. Melchart D, Weidenhammer W, Streng A, et al. prospective
investigation of adverse effects of acupuncture in 97733
patients. Arch Inter Med. 2004;164:104–105.
17. Yamashita H, Tsukayama H, Hori N, et al. Incidence of
adverse reactions associated with acupuncture. J Altern
CONCLUSIONS Complement Med. 2000;6:345–350.
Despite the limitations, this randomized, controlled 18. Witt C, Brinkhaus B, Jena S, et al. Acupuncture in patients with
study indicates that short-term acupuncture treatment is as osteoarthritis of the knee: a randomized trial. Lancet. 2005;366:
effective as short-term low-dose steroid for mild-to-moder- 136–143.
ate CTS. For those who do not tolerate oral steroid or for 19. Cabyoglu MT, Ergene N, Tan U. The mechanism of
those who do not opt for surgery, acupuncture treatment Acupuncture and clinical applications. Int J Neurosci. 2006;
provides an alternative choice. We now need to assess the 116:115–125.
20. Werner RA, Andary M. Carpal tunnel syndrome: pathophysio-
long-term effects of acupuncture on mild-to-moderate CTS
logy and clinical neurophysiology. Clin Neurophysiol. 2002;113:
in a large clinical trial. 1373–1381.
21. Keir PJ, Rempel DM. Pathomechanics of peripheral nerve
REFERENCES loading. Evidence in carpal tunnel syndrome. J Hand Ther.
2005;18:259–269.
1. Katz RT. Carpal tunnel syndrome: a practical review. Am Fam 22. Kiylioglu N, Akyol A, Guney E, et al. Sympathetic skin
Physican. 1994;49:1371–1379. response in idiopathic and diabetic carpal tunnel syndrome.
2. Bland JD. Treatment of carpal tunnel syndrome. Muscle Clin Neurol Neurosurg. 2005;108:1–7.
Nerve. 2007;36:167–171. 23. Hui AC, Wong SM, Leung CH, et al. A randomized controlled
3. Jablecki CK, Andary MT, So YT, et al. Literature review of trial of surgery vs. steroid injection for carpal tunnel syndrome.
the usefulness of nerve conduction studies and electromyo- Neurology. 2005;64:2074–2078.
graphy for the evaluation of patients with carpal tunnel 24. Hui AC, Wong SM, Wong KS, et al. Oral steroids in the
syndrome. Muscle Nerve. 1993;16:1392–1414. treatment of carpal tunnel syndrome. Ann Rheum Dis. 2001;
4. Practice Parameter for Electro diagnostic studies in carpal 60:813–814.
tunnel syndrome (summary statement). American Academy of 25. Zijlstra FJ, van den Berg-de Lange I, Huygen FJ, et al. Anti-
Neurology, American Association of Electro Diagnostic inflammatory actions of acupuncture. Mediators Inflamm. 2003;
Medicine, and American Academy of Physical Medicine and 12:59–69.
Rehabilitation. Neurology. 1993;43:2404–2405. 26. Napadow V, Kettner N, Liu J, et al. Hypothalamus and
5. Jablecki CK, Andary MT, Floeter MK, et al. Practice amygdala response to acupuncture stimuli in carpal tunnel
parameter: Electro Diagnostic studies in carpal tunnel syn- syndrome. Pain. 2007;130:254–266.
drome. Report of the American Association of Electro 27. Zhang Enquin (editor in chief), Chinese Acupuncture and
Diagnostic Medicine, American Academy of Neurology, and Moxibustion, 1990 Publishing House of Shanghai College of
the American Academy of Physical Medicine and Rehabilita- Traditional Chinese Medicine.
tion. Neurology. 2002;58:1589–1592. 28. Tam LS, Leung PC, Li TK, et al. Acupuncture in the treatment
6. O’Connor D, Marshall S, Massy-Westropp N. Non-surgical of rheumatoid arthritis: a double-blind controlled pilot study.
treatment (other than steroid injection) for carpal tunnel BMC Complement Altern Med. 2007;7:35.
syndrome. Cochrane Database Syst Rev. 2003;CD003219. 29. Park J, White A, Stevinson C, et al. Validating a new non-
7. Chang MH, Chiang HT, Lee SSJ, et al. Oral drug of choice in penetrating sham acupuncture device: two randomized con-
carpal tunnel syndrome. Neurology. 1998;51:390–393. trolled trials. Acupunct Med. 2002;20:168–174.
8. Gerritsen AA, de Krom MC, Struijs MA. Conservative treatment 30. Tsukayama H, Yamashita H, Kimura T, et al. Factors that
options for carpal tunnel syndrome: a systematic review of influence the applicability of sham needle in acupuncture
randomized controlled trials. J Neurol. 2002;249:272–280. trials: two randomized, single-blind, crossover trials with
9. Delisa JA, Mackenzie K, Baran EM. Manual of Nerve acupuncture-experienced subjects. Clin J Pain. 2006;22:
Conduction Velocity and Somatosensory Evoked Potentials. 346–349.
2nd ed. New York: Raven Press; 1987. 31. Padua L, Padua R, Aprile I, et al. Multiperspective follow-up
10. Chang MH, Liao KK, Chang SP, et al. Proximal slowing in of untreated carpal tunnel syndrome: a multicenter study.
carpal tunnel syndrome resulting from either conduction block Neurology. 2001;56:1459–1466.
or retrograde degeneration. J Neurol. 1993;240:287–290. 32. Destefano F, Nordtrom DL, Vierkant RA. Long-term
11. Chang MH, Ger LP, Hsieh PF, et al. A randomized clinical symptom outcomes of carpal tunnel syndrome and its
trial of oral steroids in the treatment of carpal tunnel syn- treatment. J Hand Surg. 1997;22:200–210.
drome: a long-term follow up. J Neurol Neurosurg Psychiatry. 33. Muller M, Tsui D, Schnurr R, et al. Effectiveness of hand
2002;73:710–714. therapy interventions in primary management of carpal
12. Chang MH, Liu LH, Lee YC, et al. Comparison of sensitivity tunnel syndrome: a systematic review. J Hand Ther. 2004;17:
of transcarpal median motor conduction velocity and conven- 210–228.